Not Yet RecruitingNot Applicable

Preemptive Analgesia in Laparoscopic Hysterectomy

70 participantsStarted 2026-02-02

Plain-language summary

The aim of this study is to evaluate the effects of ibuprofen and paracetamol administered for pre-emptive analgesia to patients undergoing laparoscopic hysterectomy on pain scores during the first 24 hours postoperatively, the amount of opioids consumed postoperatively, and adverse effects such as postoperative nausea and vomiting.

Who can participate

Age range18 Years – 70 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged 18-70 * ASA I-III patients * Patients undergoing elective laparoscopic hysterectomy surgery Exclusion Criteria: * Emergency surgery * Patients who require conversion to abdominal hysterectomy during the intraoperative period * Those with severe liver or kidney failure, a history of long-term nonsteroidal anti-inflammatory and opioid analgesic use * Those with a history of gastrointestinal bleeding, peptic ulcer or inflammatory bowel disease, diabetes or other neuropathic diseases * Patients unable to use patient-controlled analgesia (PCA) devices

What they're measuring

Postoperative analgesia

Timeframe: from the end of surgery up to 24 hours postopeartively

Trial details

NCT IDNCT07401927

SponsorGiresun University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-04-01

View on ClinicalTrials.gov More Postoperative Analgesia trials